SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
37 hedge funds and large institutions have $90.1M invested in scPharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 14 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.22% less ownership
Funds ownership: 58.25% → 58.03% (-0.22%)
43% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 14
Holders
37
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$822K | |
| 2 | +$390K | |
| 3 | +$231K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$179K |
| 5 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$134K |
Top Sellers
| 1 | -$1.72M | |
| 2 | -$411K | |
| 3 | -$189K | |
| 4 |
Millennium Management
New York
|
-$48.8K |
| 5 |
Renaissance Technologies
New York
|
-$16.5K |